Hsu Yu-Juei, Chen Yeu-Chin, Ho Ching-Liang, Kao Woei-Yau, Chao Tsu-Yi
Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Sep;65(9):441-5.
Diabetic ketoacidosis (DKA) and pancreatic pseudocysts are rare complications following treatment of hematological malignancies with L-asparaginase (L-asp). Persistent hyperglycemia with recurrent DKA presenting as a long-term complication of L-asp-induced pancreatitis is even rarer. A 21-year-old man with pre-B-type acute lymphoblastic leukemia (ALL) developed pancreatic pseudocysts, DKA and persistent hyperglycemia after L-asp therapy. The patient was treated with oral hypoglycemic agents (OHA) for sugar control thereafter. Ten months later, another episode of DKA developed during relapsed ALL without having obvious precipitating factors. Insulin was then instituted for control of his blood sugar until death. The leukemic process may play some role in glucose homeostasis and may be considered as a precipitating factor for DKA. The patient finally died of disease progression of ALL and sepsis 2 years after the initial diagnosis of ALL.
糖尿病酮症酸中毒(DKA)和胰腺假性囊肿是使用L-天冬酰胺酶(L-asp)治疗血液系统恶性肿瘤后的罕见并发症。L-asp诱导的胰腺炎的长期并发症表现为持续性高血糖伴复发性DKA则更为罕见。一名21岁的前B型急性淋巴细胞白血病(ALL)男性患者在接受L-asp治疗后出现了胰腺假性囊肿、DKA和持续性高血糖。此后该患者接受口服降糖药(OHA)治疗以控制血糖。十个月后,在复发的ALL期间又发生了一次DKA发作,且没有明显的诱发因素。随后开始使用胰岛素控制血糖直至患者死亡。白血病病程可能在葡萄糖稳态中起一定作用,可被视为DKA的诱发因素。该患者在初次诊断ALL两年后最终死于ALL疾病进展和败血症。